CN Stock MarketDetailed Quotes

688293 Shanghai OPM Biosciences

Watchlist
  • 47.89
  • -0.09-0.19%
Noon Break Dec 3 11:29 CST
5.50BMarket Cap144.25P/E (TTM)

Shanghai OPM Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
25.73%215.86M
18.44%143.61M
17.36%79.71M
-17.41%243.12M
-23.05%171.69M
-17.36%121.25M
-6.53%67.92M
38.41%294.37M
47.58%223.11M
78.08%146.72M
Operating revenue
25.73%215.86M
18.44%143.61M
17.36%79.71M
-17.41%243.12M
-23.05%171.69M
-17.36%121.25M
-6.53%67.92M
38.41%294.37M
47.58%223.11M
78.08%146.72M
Total operating cost
40.35%186.06M
40.25%118.23M
35.52%58.92M
4.21%197.37M
-1.36%132.57M
-4.96%84.3M
-1.42%43.48M
20.72%189.39M
23.35%134.39M
34.64%88.69M
Operating cost
29.94%91.85M
23.62%57.5M
15.44%27.09M
-5.67%100.05M
-4.69%70.69M
-4.09%46.51M
-9.14%23.47M
24.31%106.06M
33.18%74.17M
45.52%48.5M
Operating tax surcharges
169.22%1.33M
240.29%952.69K
554.85%590.97K
-41.17%686.73K
-52.96%493.92K
-63.21%279.97K
-80.17%90.24K
50.04%1.17M
98.28%1.05M
487.16%761.04K
Operating expense
59.89%18.74M
70.56%12.52M
65.47%4.97M
18.84%16.16M
18.67%11.72M
27.46%7.34M
13.96%3.01M
31.61%13.6M
34.18%9.88M
54.61%5.76M
Administration expense
76.56%61.72M
92.01%43.23M
78.61%21.7M
25.70%58.22M
12.80%34.96M
11.87%22.52M
27.41%12.15M
14.20%46.31M
1.71%30.99M
6.60%20.13M
Financial expense
35.91%-11.56M
13.02%-11.35M
36.03%-3.18M
-90.04%-20.81M
-198.51%-18.04M
-6,337.53%-13.05M
-1,942.26%-4.97M
-5,297.23%-10.95M
-3,015.10%-6.04M
-24.27%-202.75K
-Interest expense (Financial expense)
-1.60%2.37M
63.54%1.58M
-20.99%764.1K
-35.29%3.23M
-37.87%2.41M
-65.19%967.05K
-32.93%967.05K
4.14%4.98M
11.42%3.88M
23.74%2.78M
-Interest Income (Financial expense)
15.67%-15.61M
-84.87%-12.2M
42.14%-3.82M
-67.99%-23.25M
-177.13%-18.51M
-436.69%-6.6M
-436.69%-6.6M
-183.06%-13.84M
-98.60%-6.68M
51.41%-1.23M
Research and development
-26.75%23.99M
-25.71%15.38M
-20.43%7.74M
29.70%43.06M
34.50%32.75M
50.53%20.7M
81.11%9.73M
68.60%33.2M
65.71%24.35M
37.89%13.75M
Credit Impairment Loss
-36.56%-4.88M
-21.64%-4.63M
-216.83%-1.98M
-35.03%-6.42M
-23.24%-3.58M
-149.56%-3.81M
6.51%-624.17K
-1,418.63%-4.76M
-647.83%-2.9M
-36.42%-1.53M
Asset Impairment Loss
1,020.05%722.31K
81.08%607.21K
391.35%234.47K
-58.47%-418.96K
70.13%-78.51K
277.25%335.33K
-433.43%-80.48K
-213.33%-264.38K
-2,513.75%-262.82K
-612.94%-189.18K
Other net revenue
Fair value change income
-59.58%2.56M
-54.28%2.39M
900.66%809.43K
-7.95%1.53M
742.85%6.32M
--5.23M
---101.1K
--1.67M
--750.01K
----
Invest income
83.62%9.28M
80.61%4.92M
-8.93%2.63M
215.37%13.06M
95.50%5.05M
63.57%2.72M
270.46%2.88M
-0.89%4.14M
-18.61%2.58M
-13.99%1.67M
Asset deal income
--86.85K
--86.85K
----
----
----
----
----
--292.21K
--77.91K
--77.91K
Other revenue
32.86%2.64M
-7.55%1.37M
-26.88%625.26K
-15.88%8.3M
-63.22%1.99M
-10.79%1.48M
-4.02%855.06K
112.92%9.86M
123.48%5.4M
-0.76%1.66M
Operating profit
-17.69%40.19M
-29.81%30.12M
-15.60%23.11M
-46.68%61.81M
-48.26%48.83M
-28.13%42.91M
-7.36%27.37M
80.54%115.92M
98.92%94.37M
214.64%59.71M
Add:Non operating Income
-52.31%23.5K
-99.99%4.07
-100.00%0.72
-98.65%49.28K
-98.06%49.28K
-98.05%48.97K
-72.82%29.39K
-9.13%3.64M
-36.56%2.54M
27,365.95%2.51M
Less:Non operating expense
475.79%977.59K
36.32%64.07K
43.29%10.03K
48.91%186.57K
301.51%169.78K
11.98%47K
-82.50%7K
107.08%125.29K
3,232.94%42.29K
3,208.19%41.97K
Total profit
-19.44%39.24M
-29.97%30.05M
-15.70%23.1M
-48.37%61.67M
-49.72%48.71M
-30.99%42.91M
-7.50%27.4M
75.24%119.43M
88.29%96.87M
227.52%62.18M
Less:Income tax cost
111.87%12.6M
18.04%6.25M
10.84%3.69M
-40.21%8.41M
-56.83%5.95M
-40.00%5.29M
-23.43%3.33M
81.26%14.06M
161.05%13.78M
35,590.79%8.82M
Add:Adjusted items effecting net profit
---0.01
----
----
----
----
----
----
----
----
----
Net profit
-37.71%26.64M
-36.72%23.81M
-19.37%19.4M
-49.45%53.26M
-48.54%42.76M
-29.50%37.62M
-4.76%24.07M
74.47%105.37M
79.97%83.09M
181.43%53.36M
Net profit from continuing operation
-37.71%26.64M
-36.72%23.81M
-19.37%19.4M
-49.42%53.29M
-48.54%42.76M
-29.50%37.62M
-4.76%24.07M
74.47%105.37M
79.97%83.09M
181.43%53.36M
Net income from discontinuing operating
----
----
----
---31.17K
----
----
----
----
----
----
Less:Minority Profit
-41.83%-599.71K
-24.58%-332.8K
-39.84%-175.04K
---778.57K
---422.85K
---267.15K
---125.17K
----
----
----
Net profit of parent company owners
-36.93%27.23M
-36.29%24.14M
-19.07%19.58M
-48.72%54.04M
-48.03%43.18M
-29.00%37.89M
-4.26%24.19M
74.47%105.37M
79.97%83.09M
181.43%53.36M
Add:Adjusted items effecting net profit of parent company owners
---0.01
----
----
----
----
----
----
----
----
----
Earning per share
Basic earning per share
-36.84%0.24
-36.36%0.21
-19.05%0.17
-54.81%0.47
-70.77%0.38
-62.07%0.33
-48.78%0.21
6.12%1.04
73.33%1.3
180.65%0.87
Diluted earning per share
-36.84%0.24
-36.36%0.21
-19.05%0.17
-54.81%0.47
-70.77%0.38
-62.07%0.33
-48.78%0.21
6.12%1.04
73.33%1.3
180.65%0.87
Other composite income
-26.49%105.66K
-93.77%18.62K
-87.02%10.7K
-36.56%75.43K
143.74K
298.72K
82.44K
118.91K
Other composite income of parent company owners
----
-93.77%18.62K
-87.02%10.7K
-36.56%75.43K
----
--298.72K
--82.44K
--118.91K
----
----
Add:Adjusted items effecting composite income
26.49%-105.66K
----
100.00%-0.01
----
---143.74K
---298.72K
---82.44K
----
----
----
Total composite income
-37.71%26.64M
-36.67%23.82M
-19.33%19.41M
-49.44%53.34M
-48.54%42.76M
-29.50%37.62M
-4.76%24.07M
74.67%105.49M
79.97%83.09M
181.43%53.36M
Total composite income of parent company owners
-36.93%27.23M
-36.24%24.16M
-19.02%19.59M
-48.70%54.11M
-48.03%43.18M
-29.00%37.89M
-4.26%24.19M
74.67%105.49M
79.97%83.09M
181.43%53.36M
Total composite income of minority owners
-41.83%-599.71K
-24.58%-332.8K
-39.84%-175.04K
---778.57K
---422.85K
---267.15K
---125.17K
----
----
----
Add:Adjusted items effecting total composite income
----
----
---0.01
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 25.73%215.86M18.44%143.61M17.36%79.71M-17.41%243.12M-23.05%171.69M-17.36%121.25M-6.53%67.92M38.41%294.37M47.58%223.11M78.08%146.72M
Operating revenue 25.73%215.86M18.44%143.61M17.36%79.71M-17.41%243.12M-23.05%171.69M-17.36%121.25M-6.53%67.92M38.41%294.37M47.58%223.11M78.08%146.72M
Total operating cost 40.35%186.06M40.25%118.23M35.52%58.92M4.21%197.37M-1.36%132.57M-4.96%84.3M-1.42%43.48M20.72%189.39M23.35%134.39M34.64%88.69M
Operating cost 29.94%91.85M23.62%57.5M15.44%27.09M-5.67%100.05M-4.69%70.69M-4.09%46.51M-9.14%23.47M24.31%106.06M33.18%74.17M45.52%48.5M
Operating tax surcharges 169.22%1.33M240.29%952.69K554.85%590.97K-41.17%686.73K-52.96%493.92K-63.21%279.97K-80.17%90.24K50.04%1.17M98.28%1.05M487.16%761.04K
Operating expense 59.89%18.74M70.56%12.52M65.47%4.97M18.84%16.16M18.67%11.72M27.46%7.34M13.96%3.01M31.61%13.6M34.18%9.88M54.61%5.76M
Administration expense 76.56%61.72M92.01%43.23M78.61%21.7M25.70%58.22M12.80%34.96M11.87%22.52M27.41%12.15M14.20%46.31M1.71%30.99M6.60%20.13M
Financial expense 35.91%-11.56M13.02%-11.35M36.03%-3.18M-90.04%-20.81M-198.51%-18.04M-6,337.53%-13.05M-1,942.26%-4.97M-5,297.23%-10.95M-3,015.10%-6.04M-24.27%-202.75K
-Interest expense (Financial expense) -1.60%2.37M63.54%1.58M-20.99%764.1K-35.29%3.23M-37.87%2.41M-65.19%967.05K-32.93%967.05K4.14%4.98M11.42%3.88M23.74%2.78M
-Interest Income (Financial expense) 15.67%-15.61M-84.87%-12.2M42.14%-3.82M-67.99%-23.25M-177.13%-18.51M-436.69%-6.6M-436.69%-6.6M-183.06%-13.84M-98.60%-6.68M51.41%-1.23M
Research and development -26.75%23.99M-25.71%15.38M-20.43%7.74M29.70%43.06M34.50%32.75M50.53%20.7M81.11%9.73M68.60%33.2M65.71%24.35M37.89%13.75M
Credit Impairment Loss -36.56%-4.88M-21.64%-4.63M-216.83%-1.98M-35.03%-6.42M-23.24%-3.58M-149.56%-3.81M6.51%-624.17K-1,418.63%-4.76M-647.83%-2.9M-36.42%-1.53M
Asset Impairment Loss 1,020.05%722.31K81.08%607.21K391.35%234.47K-58.47%-418.96K70.13%-78.51K277.25%335.33K-433.43%-80.48K-213.33%-264.38K-2,513.75%-262.82K-612.94%-189.18K
Other net revenue
Fair value change income -59.58%2.56M-54.28%2.39M900.66%809.43K-7.95%1.53M742.85%6.32M--5.23M---101.1K--1.67M--750.01K----
Invest income 83.62%9.28M80.61%4.92M-8.93%2.63M215.37%13.06M95.50%5.05M63.57%2.72M270.46%2.88M-0.89%4.14M-18.61%2.58M-13.99%1.67M
Asset deal income --86.85K--86.85K----------------------292.21K--77.91K--77.91K
Other revenue 32.86%2.64M-7.55%1.37M-26.88%625.26K-15.88%8.3M-63.22%1.99M-10.79%1.48M-4.02%855.06K112.92%9.86M123.48%5.4M-0.76%1.66M
Operating profit -17.69%40.19M-29.81%30.12M-15.60%23.11M-46.68%61.81M-48.26%48.83M-28.13%42.91M-7.36%27.37M80.54%115.92M98.92%94.37M214.64%59.71M
Add:Non operating Income -52.31%23.5K-99.99%4.07-100.00%0.72-98.65%49.28K-98.06%49.28K-98.05%48.97K-72.82%29.39K-9.13%3.64M-36.56%2.54M27,365.95%2.51M
Less:Non operating expense 475.79%977.59K36.32%64.07K43.29%10.03K48.91%186.57K301.51%169.78K11.98%47K-82.50%7K107.08%125.29K3,232.94%42.29K3,208.19%41.97K
Total profit -19.44%39.24M-29.97%30.05M-15.70%23.1M-48.37%61.67M-49.72%48.71M-30.99%42.91M-7.50%27.4M75.24%119.43M88.29%96.87M227.52%62.18M
Less:Income tax cost 111.87%12.6M18.04%6.25M10.84%3.69M-40.21%8.41M-56.83%5.95M-40.00%5.29M-23.43%3.33M81.26%14.06M161.05%13.78M35,590.79%8.82M
Add:Adjusted items effecting net profit ---0.01------------------------------------
Net profit -37.71%26.64M-36.72%23.81M-19.37%19.4M-49.45%53.26M-48.54%42.76M-29.50%37.62M-4.76%24.07M74.47%105.37M79.97%83.09M181.43%53.36M
Net profit from continuing operation -37.71%26.64M-36.72%23.81M-19.37%19.4M-49.42%53.29M-48.54%42.76M-29.50%37.62M-4.76%24.07M74.47%105.37M79.97%83.09M181.43%53.36M
Net income from discontinuing operating ---------------31.17K------------------------
Less:Minority Profit -41.83%-599.71K-24.58%-332.8K-39.84%-175.04K---778.57K---422.85K---267.15K---125.17K------------
Net profit of parent company owners -36.93%27.23M-36.29%24.14M-19.07%19.58M-48.72%54.04M-48.03%43.18M-29.00%37.89M-4.26%24.19M74.47%105.37M79.97%83.09M181.43%53.36M
Add:Adjusted items effecting net profit of parent company owners ---0.01------------------------------------
Earning per share
Basic earning per share -36.84%0.24-36.36%0.21-19.05%0.17-54.81%0.47-70.77%0.38-62.07%0.33-48.78%0.216.12%1.0473.33%1.3180.65%0.87
Diluted earning per share -36.84%0.24-36.36%0.21-19.05%0.17-54.81%0.47-70.77%0.38-62.07%0.33-48.78%0.216.12%1.0473.33%1.3180.65%0.87
Other composite income -26.49%105.66K-93.77%18.62K-87.02%10.7K-36.56%75.43K143.74K298.72K82.44K118.91K
Other composite income of parent company owners -----93.77%18.62K-87.02%10.7K-36.56%75.43K------298.72K--82.44K--118.91K--------
Add:Adjusted items effecting composite income 26.49%-105.66K----100.00%-0.01-------143.74K---298.72K---82.44K------------
Total composite income -37.71%26.64M-36.67%23.82M-19.33%19.41M-49.44%53.34M-48.54%42.76M-29.50%37.62M-4.76%24.07M74.67%105.49M79.97%83.09M181.43%53.36M
Total composite income of parent company owners -36.93%27.23M-36.24%24.16M-19.02%19.59M-48.70%54.11M-48.03%43.18M-29.00%37.89M-4.26%24.19M74.67%105.49M79.97%83.09M181.43%53.36M
Total composite income of minority owners -41.83%-599.71K-24.58%-332.8K-39.84%-175.04K---778.57K---422.85K---267.15K---125.17K------------
Add:Adjusted items effecting total composite income -----------0.01----------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data